The Round is Led by Growth Fund IRIS Alongside Five Arrows

本轮融资由成长型基金 IRIS 领投，Five Arrows 跟投

Funding Will Fuel Implicity’s Next Phase of Growth in the US Through Local Commercial Hires, Build on Its Established Leadership Across Europe, and Accelerate Further AI Investment

这笔资金将推动 Implicity 在美国进入下一阶段的成长，包括在当地招聘商业人才，巩固其在欧洲市场的既有领导地位，并加速进一步的人工智能投资。

Implicity Already Serves Over 250 Medical Centers and Monitors 120,000+ Patients Daily Across the US, France, and Germany

Implicity 已为超过 250 家医疗中心提供服务，每天在美国、法国和德国监测 12 万多名患者

Implicity

隐式地

, a global leader in AI-driven cardiac remote monitoring, has secured a $40 million funding round led by European tech growth capital firm

，作为人工智能驱动的心脏远程监测领域的全球领导者，已完成由欧洲科技成长资本公司领投的4,000万美元融资。

IRIS

虹膜

, alongside

，以及

Five Arrows, the alternative assets arm of Rothschild & Co.

五箭资本，罗斯柴尔德公司的另类资产部门。

Enabling Clinicians to Act on Cardiac Data at Scale

使临床医生能够大规模地根据心脏数据采取行动

Remote patient monitoring has become the standard of care in cardiology following the

在……之后，远程患者监测已成为心脏病学领域的护理标准

2023 HRS/EHRA/APHRS/LAHRS Expert Consensus

2023年HRS/EHRA/APHRS/LAHRS专家共识

. Today, care teams manage more sources than ever, from cardiac implantable electronic devices to heart failure monitoring. While each new data stream provides valuable clinical insight, it also adds complexity for the clinicians piecing the full picture together. Too much time is spent navigating multiple systems and triaging alerts to identify events that require action.

如今，护理团队需要管理的数据源数量前所未有，范围涵盖心脏植入式电子设备到心力衰竭监测。虽然每个新的数据流都提供了宝贵的临床洞察，但也为 clinicians 拼凑完整病情图景增加了复杂性。大量时间被耗费在穿梭于多个系统之间以及对警报进行分诊，以识别需要采取行动的事件。

This administrative burden reduces time available for direct patient care, potentially delaying responses to the events that matter most..

这种行政负担减少了用于直接患者护理的时间，可能会延迟对最重要事件的响应。

Implicity helps to solve this with a single, AI-driven platform that aggregates, normalizes, and analyzes data across the full continuum, regardless of device manufacturer. It also integrates with EHRs to streamline providers’ workflow. By bringing every signal into one intelligent view, Implicity lets clinicians spend less time searching through the noise and more time on patient care..

Implicity 通过一个统一的、由人工智能驱动的平台帮助解决这一问题，该平台能够聚合、标准化并分析跨越整个连续护理过程的数据，且不受设备制造商的限制。它还与电子健康记录（EHR）系统集成，以简化医疗服务提供者的工作流程。通过将所有信号整合到一个智能视图中，Implicity 让临床医生减少在杂乱信息中搜寻的时间，从而将更多精力投入到患者护理中。

“I didn’t become a physician to manage data — I became one to treat patients,” said Dr. Arnaud Rosier, Electrophysiologist, Co-Founder and CEO at Implicity. “This funding lets us care for patients at scale, catching the information through the noise to provide the best possible care — and that’s the future of cardiology I’ve been chasing since my first year as an electrophysiologist.”.

“我成为医生并非为了管理数据，而是为了治疗患者。”Implicity 公司的电生理学家、联合创始人兼首席执行官 Arnaud Rosier 博士表示。“这笔融资使我们能够大规模地为患者提供护理，从纷繁复杂的信息中捕捉关键数据，以提供尽可能最佳的照护——这正是我自从事电生理学第一年起便一直追寻的心脏病学未来。”

Proven Clinical Impact and Market Traction

经证实的临床影响与市场认可

Unlike traditional remote monitoring solutions, Implicity has built deep clinical credibility through its FDA-cleared AI algorithms and extensive real-world evidence. Patients monitored with Implicity have seen a

与传统的远程监测解决方案不同，Implicity 凭借其获得美国食品药品监督管理局（FDA） clearance 的人工智能算法以及广泛的真实世界证据，建立了深厚的临床信誉。接受 Implicity 监测的患者已显示出

26% reduction in mortality and a 4% reduction in hospitalizations

死亡率降低26%，住院率降低4%

, compared to those on conventional remote monitoring. SignalHF, Implicity’s

，与传统的远程监测相比。SignalHF，Implicity 的

heart failure prediction algorithm

心力衰竭预测算法

, gives clinicians early visibility into a patient’s heart failure risk to support earlier identification and intervention. The platform’s ECG Analyzer feature also

，使临床医生能够及早了解患者的心力衰竭风险，从而支持早期识别和干预。该平台的ECG分析器功能还

reduces false alarms by up to 76%

将误报率降低高达76%

, so

，所以

clinicians spend less time sorting through alerts and more time with the patients who need them most

临床医生花在筛选警报上的时间减少，而将更多时间用于照顾最需要的患者。

.

。

The fundraising will support Implicity’s next phase of growth in the US. The company has built its hospital network on the ground from its Cambridge, MA base, earning the endorsement of clinicians and forging partnerships with local physicians. The round will be used for commercial hiring to widen that footprint and the development of US-specific features for one of the world’s largest healthcare markets.

本轮融资将支持 Implicity 在美国的下一阶段增长。该公司以马萨诸塞州剑桥为基地，从零开始构建了其医院网络，赢得了临床医生的认可，并与当地医师建立了合作伙伴关系。此轮融资所得将用于商业团队招聘，以扩大市场覆盖范围，并针对这个全球最大的医疗保健市场之一开发美国专属功能。

It will also fund continued investment in the company’s AI and innovation roadmap — including the next generation of Heart Failure prediction algorithms — to better serve medical teams and optimize care for remotely monitored patients..

此外，还将为公司的人工智能与创新路线图提供持续投资支持——包括下一代心力衰竭预测算法——以更好地服务医疗团队并优化远程监测患者的护理。

Nicolas Herschtel, Partner at IRIS’ Growth team, added, “In the evolving healthtech landscape, long-term success requires a rare combination of robust technology, strict regulatory clearance, and undeniable clinical utility. Implicity has proven to be a highly trusted partner to complex health systems because its platform directly addresses the administrative and operational crisis facing hospital workforces today.

IRIS增长团队合伙人尼古拉斯·赫施特尔补充道：“在不断变化的健康科技格局中，长期的成功需要罕见地结合强大的技术、严格的监管审批以及无可争议的临床实用性。Implicity已被证明是复杂医疗系统高度信赖的合作伙伴，因为其平台直接应对了当今医院 workforce 所面临的行政和运营危机。”

We are thrilled to back the team as they cement their leadership in the US market and drive the next phase of digital healthcare infrastructure.”.

我们很高兴支持该团队，助力其巩固在美国市场的领导地位，并推动数字医疗健康基础设施的下一阶段发展。

François-Xavier Lehman, Director at Five Arrows, commented, “Implicity is a rare company where clinical superiority, regulatory credibility and genuine patient impact come together at scale. By turning fragmented cardiac data into action, it improves outcomes for patients while relieving the operational pressure on hospital teams.

Five Arrows 董事 François-Xavier Lehman 表示：“Implicity 是一家罕见的企业，它在规模化层面将临床优势、监管可信度与真正的患者影响融为一体。通过将分散的心脏数据转化为 actionable 的干预措施，它在改善患者预后的同时，缓解了医院团队的运营压力。”

This is precisely the kind of sustainable, mission-driven business we seek to support.”.

“这正是我们寻求支持的可持续、使命驱动型企业。”

About Implicity

关于 Implicity

Implicity is a digital medtech company specializing in cardiac remote monitoring. Its platform embeds proprietary algorithms, certified as medical devices, that improve clinical efficiency and predictive accuracy. The company’s independent, universal platform monitors patients with cardiac implantable electronic devices (CIEDs) and heart failure, turning their data into actionable insights for cardiologists and medical teams.

Implicity 是一家专注于心脏远程监测的数字医疗科技公司。其平台嵌入了经认证为医疗器械的专有算法，能够提高临床效率和预测准确性。该公司的独立通用平台可监测植入心脏电子器械（CIED）的患者以及心力衰竭患者，将其数据转化为可供心脏病学家和医疗团队采取行动的洞察。

Implicity supports medical teams across Europe and the United States in delivering more efficient, predictive, and proactive cardiac care..

Implicity 支持欧洲和美国的医疗团队，提供更高效、可预测且主动的心脏病护理。

About IRIS

关于 IRIS

IRIS is a European Growth and Venture capital equity firm specialized in tech, investing in seed, Series A, late-stage, and growth. With offices and teams in Berlin, Munich, and Paris, and a keen understanding of their markets and a robust international network, IRIS is a selective partner to the upcoming scale-ups and tech giants, helping them increase their visibility, business reach, and impact across the world.

IRIS 是一家专注于科技领域的欧洲成长型与风险资本股权投资公司，投资阶段涵盖种子轮、A 轮、后期及成长期。公司在柏林、慕尼黑和巴黎设有办公室并组建专业团队，凭借对当地市场的深刻洞察以及强大的国际网络，IRIS 成为新兴规模化企业和科技巨头的精选合作伙伴，助力其提升全球知名度、业务覆盖范围及影响力。

IRIS investments include, among others, Adjust, Braincube, Escape, Exotec, Kyriba, Jedox, LeanIX, LumApps, Open-Xchange, pyck, Red Points, Shift Technology, Spinergie, SurePay, Talend, Talon.one, and Zeta Global. For more information, visit.

IRIS 的投资包括（但不限于）Adjust、Braincube、Escape、Exoste、Kyriba、Jedox、LeanIX、LumApps、Open-Xchange、pyck、Red Points、Shift Technology、Spinergie、SurePay、Talend、Talon.one 和 Zeta Global。欲了解更多信息，请访问。

iris.vc

iris.vc

.

。

About Five Arrows

关于五箭

Five Arrows is the alternative assets arm of Rothschild & Co and has more than €34 billion in assets under management, with offices in Paris, London, New York, Los Angeles, San Francisco, and Luxembourg.

Five Arrows 是罗斯柴尔德公司（Rothschild & Co）旗下的另类资产管理部门，管理资产规模超过340亿欧元，在巴黎、伦敦、纽约、洛杉矶、旧金山和卢森堡设有办事处。

This investment was made through the Five Arrows Sustainable Investments (FASI) fund, a direct minorities SFDR Article 9 fund.

该项投资通过五箭可持续投资（FASI）基金进行，该基金是一只直接少数股权投资且符合《可持续金融披露条例》（SFDR）第9条的基金。

For more information, please visit

更多信息，请访问

rothschildandco.com/en/five-arrows/multi-strategies/fasi/

rothschildandco.com/en/five-arrows/multi-strategies/fasi/

.

。

Originally announced September 9th, 2026

最初于2026年9月9日宣布

Get Fresh Healthcare & IT Stories Delivered Daily

每日获取最新的医疗与IT资讯

Join thousands of your healthcare & HealthIT peers who subscribe to our daily newsletter.

加入成千上万的医疗保健与健康信息技术同行，订阅我们的每日通讯。

We respect your privacy and will never sell or give out your contact information

我们尊重您的隐私，绝不会出售或泄露您的联系方式。